Institut de Genie Chimique, Laboratoire de Biotechnologie Cellulaire et Moleculaire, EPF, Lausanne, Switzerland.
Cytotechnology. 1996 Jan;21(3):205-15. doi: 10.1007/BF00365343.
The importance of mammalian cell cultures for biotechnological production processes is steadily increasing, despite the high demands of these organisms on their culture conditions. Efforts towards a more efficient bioprocess generally concentrate on maximizing the culture's life time, the cell number, and the product concentration. Here recombinant BHK 21 c13 cells are used to produce rh-AT III, an anticoagulant of high therapeutic value. The influence of the process mode (batch, repeated batch, continuous perfusion) and the process temperature (30°C vs. 37°C) on the above mentioned parameters is investigated. It is possible to increase the length of the culture from 140 h (batch) to more than 500 h (continuous perfusion culture), while concomitantly increasing the cell density from 0.72 10(6)/ml (batch) to 2.27 10(6)/ml (repeated batch) and 2.87 10(6)/ml (continuous perfusion culture). The accumulation of toxic metabolites, such as lactate, can be curtailed by reducing the bioreactor temperature from 37°C to 30°C during the later part of the exponential growth phase. Fast and reliable product monitoring became essential during process optimization. Capillary zone electrophoresis (CZE) in uncoated fused silica capillaries was studied for that purpose and compared to the standard ELISA. Under optimized conditions an AT III quantification could be done within 2 min with CZE. The detection limit was 5 μg/ml. A relative standard deviation of less than 0.9% was calculated. The detection limit could be lowered by one order of magnitude by using a two dimensional system, where an liquid chromatographic (LC) system is coupled to the CZE. Concomitantly the resolution is improved. The two-dimensional analysis required 5 min. Membrane adsorbers (MA) were used as stationary phase in the LC-system, to allow the application of high flow rates (5-10 ml/min). The correlation between the LC-CZE analysis and the standard AT III-ELISA was excellent, with r(2): 0.965. Using the assay for at line product monitoring, it is shown, that the process temperature is of no consequence for the productivity whereas the process mode strongly influences this parameter.
哺乳动物细胞培养在生物技术生产过程中的重要性日益增加,尽管这些生物体对其培养条件有很高的要求。提高生物工艺效率的努力通常集中在最大限度地延长培养时间、细胞数量和产物浓度上。在这里,重组 BHK 21 c13 细胞被用于生产 rh-AT III,一种具有高治疗价值的抗凝剂。研究了过程模式(分批、重复分批、连续灌注)和过程温度(30°C 与 37°C)对上述参数的影响。可以将培养时间从 140 小时(分批)延长到 500 小时以上(连续灌注培养),同时将细胞密度从 0.72 10(6)/ml(分批)提高到 2.27 10(6)/ml(重复分批)和 2.87 10(6)/ml(连续灌注培养)。通过在指数生长期后期将生物反应器温度从 37°C 降低到 30°C,可以减少乳酸等有毒代谢物的积累。在优化过程中,快速可靠的产物监测变得至关重要。为此,研究了未涂层熔融石英毛细管中的毛细管区带电泳(CZE),并将其与标准 ELISA 进行了比较。在优化条件下,使用 CZE 可以在 2 分钟内完成 AT III 的定量分析。检测限为 5μg/ml。计算出相对标准偏差小于 0.9%。通过使用二维系统,将检测限降低了一个数量级,其中液相色谱(LC)系统与 CZE 耦合。同时,分辨率得到了提高。二维分析需要 5 分钟。膜吸附剂(MA)被用作 LC 系统中的固定相,以允许应用高流速(5-10ml/min)。LC-CZE 分析与标准 AT III-ELISA 之间的相关性非常好,r(2):0.965。使用该测定法进行在线产物监测,表明过程温度对生产率没有影响,而过程模式对该参数有很大影响。